Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy.
about
Sudden Death Following Exercise; a Case Series.Comparison of two European models estimating risk of -sudden cardiac death in hypertrophic cardiomyopathy.Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy.Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives.Mechanical dispersion and global longitudinal strain by speckle tracking echocardiography: Predictors of appropriate implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy.Hypertrophic Cardiomyopathy: New Evidence Since the 2011 American Cardiology of Cardiology Foundation and American Heart Association Guideline.Prevention of sudden death in hypertrophic cardiomyopathy: bridging the gaps in knowledge.ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy.Sudden cardiac death in nonischemic cardiomyopathy: Refining risk assessment.Appropriate Implantable Defibrillator Therapy in Adults With Hypertrophic Cardiomyopathy.Life-long tailoring of management for patients with hypertrophic cardiomyopathy : Awareness and decision-making in changing scenarios.Comparison of the Prognostic Usefulness of the European Society of Cardiology and American Heart Association/American College of Cardiology Foundation Risk Stratification Systems for Patients With Hypertrophic Cardiomyopathy.Left ventricular twist in hypertrophic cardiomyopathy : Predictor of nonsustained ventricular tachycardia.Hypertrophic Cardiomyopathy-Past, Present and Future.ESC sudden-death risk model in hypertrophic cardiomyopathy: Incremental value of quantitative contrast-enhanced CMR in intermediate-risk patients.High T2-weighted signal intensity for risk prediction of sudden cardiac death in hypertrophic cardiomyopathy.Validation of the HCM Risk-SCD model in patients with hypertrophic cardiomyopathy following alcohol septal ablation.Distinct ECG Phenotypes Identified in Hypertrophic Cardiomyopathy Using Machine Learning Associate With Arrhythmic Risk Markers.Relationship between left ventricular diastolic dyssynchrony and systolic dyssynchrony in hypertrophic cardiomyopathy by single-cardiac real-time three-dimensional ultrasonography.Prognostic value of cardiovascular magnetic resonance imaging for life-threatening arrhythmia detected by implantable cardioverter-defibrillator in Japanese patients with hypertrophic cardiomyopathy.Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: What has Changed in The Guidelines?Prevention of Sudden Death in Hypertrophic Cardiomyopathy.Hypertrophic cardiomyopathy: Sudden cardiac death risk stratification in adults
P2860
Q33167265-6AC94837-2A64-4E11-AA6E-0F7A3B1BCF07Q33168882-13AB4868-3A8E-42FC-B398-73F0E0378DAEQ37741732-C55E5FA6-A534-4A71-BE13-AE63015980A6Q38816364-4B288803-4F2F-4FE8-933B-AD8B4BF560A2Q38818980-7ECB15A2-52FC-4B59-BCCC-717035230232Q38863215-AAC8683B-1119-493B-A675-F9E6AAEA05D0Q38884022-01FFCBC0-F373-4312-A19A-9C8C58FD4DFCQ39003149-8CBA62C0-0821-48A8-BEB4-1B6D5CD6DB32Q39410638-EC5D3792-C88E-4C3B-BC8B-B08C7965200CQ39801126-29DD3FEE-EE85-406E-8461-E53615E026D4Q42320941-16B54BB2-3A13-46E3-8D2E-AB7EFD39C49CQ47371803-C325C174-55FE-4F36-A7B2-0310D30E87B8Q47779940-862A907B-C53C-4864-AF30-8D24DCEB8759Q47787101-0C4FCBB1-F634-4753-9F93-410BB01021FEQ47801890-DE339876-BC7A-4236-94D6-406841114E5FQ49366122-12E303BF-857F-4568-B0E6-5A88F6359CE4Q50089449-928C8F08-CFEE-4646-974B-83E48F6ECCA2Q51730904-CAD1E652-48A5-4383-81CD-889A936E4CCBQ51732920-7E05ABC5-FCFE-4DA1-9031-58D152C551DAQ54164038-2D3E7DCC-FE8B-433F-B0DC-6E076FF437E0Q55427081-0C451057-DA27-465D-8DD7-C8B862086CE4Q55433755-44678C5E-FE68-4C50-ADC2-AD9C18F228DCQ58565579-EE700039-9AC4-4132-908D-5CFEC638FFDE
P2860
Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Independent Assessment of the ...... r Hypertrophic Cardiomyopathy.
@en
type
label
Independent Assessment of the ...... r Hypertrophic Cardiomyopathy.
@en
prefLabel
Independent Assessment of the ...... r Hypertrophic Cardiomyopathy.
@en
P2093
P1476
Independent Assessment of the ...... or Hypertrophic Cardiomyopathy
@en
P2093
Barry J Maron
Ethan J Rowin
Martin S Maron
Raymond H Chan
Ross F Garberich
P304
P356
10.1016/J.AMJCARD.2015.05.047
P407
P577
2015-06-04T00:00:00Z